297 related articles for article (PubMed ID: 23619512)
1. Pathology of recurrent diseases in kidney allografts: membranous nephropathy and focal segmental glomerulosclerosis.
Kowalewska J
Curr Opin Organ Transplant; 2013 Jun; 18(3):313-8. PubMed ID: 23619512
[TBL] [Abstract][Full Text] [Related]
2. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
[TBL] [Abstract][Full Text] [Related]
3. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
4. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
Shoji J; Mii A; Terasaki M; Shimizu A
Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
[TBL] [Abstract][Full Text] [Related]
5. Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study.
Gu QH; Cui Z; Huang J; Zhang YM; Qu Z; Wang F; Wang X; Wang SX; Liu G; Zhao MH
Medicine (Baltimore); 2016 May; 95(21):e3786. PubMed ID: 27227951
[TBL] [Abstract][Full Text] [Related]
6. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series.
Batal I; Vasilescu ER; Dadhania DM; Adel AA; Husain SA; Avasare R; Serban G; Santoriello D; Khairallah P; Patel A; Moritz MJ; Latulippe E; Riopel J; Khallout K; Swanson SJ; Bomback AS; Mohan S; Ratner L; Radhakrishnan J; Cohen DJ; Appel GB; Stokes MB; Markowitz GS; Seshan SV; De Serres SA; Andeen N; Loupy A; Kiryluk K; D'Agati VD
Am J Kidney Dis; 2020 Sep; 76(3):374-383. PubMed ID: 32359820
[TBL] [Abstract][Full Text] [Related]
9. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
Franco Palacios CR; Lieske JC; Wadei HM; Rule AD; Fervenza FC; Voskoboev N; Garovic VD; Zand L; Stegall MD; Cosio FG; Amer H
Transplantation; 2013 Aug; 96(4):394-9. PubMed ID: 23736353
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
[TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis recurrence in the renal allograft.
Leca N
Adv Chronic Kidney Dis; 2014 Sep; 21(5):448-52. PubMed ID: 25168835
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis after renal transplantation.
Shimizu A; Higo S; Fujita E; Mii A; Kaneko T
Clin Transplant; 2011 Jul; 25 Suppl 23():6-14. PubMed ID: 21623907
[TBL] [Abstract][Full Text] [Related]
13. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of membranous nephropathy: evolution and revolution.
Glassock RJ
Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney transplantation.
Chukwu CA; Holmberg C; Storrar J; Middleton R; Sinha S; Kalra PA; Shawki H; Rao A
Clin Transplant; 2023 Jun; 37(6):e14970. PubMed ID: 36950848
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion: A retrospective observational study.
Cheng W; Sun L; Dong H; Wang G; Ye N; Wang Y; Cheng H
Medicine (Baltimore); 2021 Jan; 100(3):e23988. PubMed ID: 33545990
[TBL] [Abstract][Full Text] [Related]
17. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
BMC Med; 2014 May; 12():81. PubMed ID: 24884842
[TBL] [Abstract][Full Text] [Related]
18. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
Jin J; Li YW; He Q
Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
[TBL] [Abstract][Full Text] [Related]
19. Urinary podocytes in primary focal segmental glomerulosclerosis.
Hara M; Yanagihara T; Kihara I
Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
